2018 update of the EULAR recommendations for the management of Behcet's syndrome
Top Cited Papers
Open Access
- 31 May 2018
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 77 (6), 808-818
- https://doi.org/10.1136/annrheumdis-2018-213225
Abstract
Several new treatment modalities with different mechanisms of action have been studied in patients with Behcet's syndrome (BS). The aim of the current effort was to update the recommendations in the light of these new data under the auspices of the European League Against Rheumatism (EULAR) Standing Committee for Clinical Affairs. A task force was formed that included BS experts from different specialties including internal medicine, rheumatology, ophthalmology, dermatology, neurology, gastroenterology, oral health medicine and vascular surgery, along with a methodologist, a health professional, two patients and two fellows in charge of the systematic literature search. Research questions were determined using a Delphi approach. EULAR standardised operating procedures was used as the framework. Results of the systematic literature review were presented to the task force during a meeting. The former recommendations were modified or new recommendations were formed after thorough discussions followed by voting. The recommendations on the medical management of mucocutaneous, joint, eye, vascular, neurological and gastrointestinal involvement of BS were modified; five overarching principles and a new recommendation about the surgical management of vascular involvement were added. These updated, evidence-based recommendations are intended to help physicians caring for patients with BS. They also attempt to highlight the shortcomings of the available clinical research with the aim of proposing an agenda for further research priorities.Keywords
Funding Information
- European League Against Rheumatism
This publication has 102 references indexed in Scilit:
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical TrialsOphthalmology, 2013
- Long-Term Outcome of Arterial Lesions in Behçet DiseaseMedicine, 2012
- Pulmonary Artery Involvement and Associated Lung Disease in Behçet DiseaseMedicine, 2012
- Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patientsBiologics: Targets and Therapy, 2011
- Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulationClinical Rheumatology, 2007
- Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's DiseaseJapanese Journal of Ophthalmology, 2007
- Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patientsBritish Journal of Ophthalmology, 2006
- Repeated Intravitreal Triamcinolone Injections in Behçet Disease That Is Resistant to Conventional Therapy: One-year ResultsAmerican Journal of Ophthalmology, 2006
- Interferon therapy for Behçet's diseaseJournal of the American Academy of Dermatology, 1994
- A Controlled Trial of Azathioprine in Behçet's SyndromeThe New England Journal of Medicine, 1990